AU2003225944A1 - Modified release dosage forms with two cores and an opening - Google Patents

Modified release dosage forms with two cores and an opening

Info

Publication number: AU2003225944A1
Authority: AU; Australia
Prior art keywords: cores; opening; dosage forms; release dosage; modified release
Prior art date: 2002-09-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003225944A

Inventor

Gerard P. Mcnally

Harry S. Swoden

David Wynn

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kenvue Brands LLC

Original Assignee

McNeil PPC Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-28

Filing date

2003-03-21

Publication date

2004-04-19

2002-09-28 Priority claimed from PCT/US2002/031129 external-priority patent/WO2003026630A1/en

2003-03-21 Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc

2003-03-21 Priority claimed from PCT/US2003/008894 external-priority patent/WO2004028508A1/en

2004-04-19 Publication of AU2003225944A1 publication Critical patent/AU2003225944A1/en

Status Abandoned legal-status Critical Current

Applications Claiming Priority (11)

Application Number	Priority Date	Filing Date	Title
PCT/US2002/031129 WO2003026630A1 (en)	2001-09-28	2002-09-28	Dosage forms having an inner core and outer shell with different shapes
AU2002347776		2002-09-28
PCT/US2002/031163 WO2003026627A1 (en)	2001-09-28	2002-09-28	Composite dosage forms
AU2002334743		2002-09-28
PCT/US2002/031117 WO2003026629A2 (en)	2001-09-28	2002-09-28	Modified release dosage forms
AUPCT/US2002/031129		2002-09-28
PCT/US2002/031024 WO2003026625A1 (en)	2001-09-28	2002-09-28	Modified release dosage forms
AUPCT/US2002/031024		2002-09-28
PCT/US2002/031062 WO2003026626A2 (en)	2001-09-28	2002-09-28	Modified release dosage forms
AU2002334741		2002-09-28
PCT/US2003/008894 WO2004028508A1 (en)	2002-09-28	2003-03-21	Modified release dosage forms with two cores and an opening

Publications (1)

Publication Number	Publication Date
AU2003225944A1 true AU2003225944A1 (en)	2004-04-19

Family

ID=34271652

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
AU2003220466A Abandoned AU2003220466A1 (en)	2002-09-28	2003-03-21	Delayed release dosage forms
AU2003225944A Abandoned AU2003225944A1 (en)	2002-09-28	2003-03-21	Modified release dosage forms with two cores and an opening
AU2003218359A Abandoned AU2003218359A1 (en)	2002-09-28	2003-03-21	Polymer composition and dosage forms comprising the same
AU2003220472A Abandoned AU2003220472A1 (en)	2002-09-28	2003-03-21	Modified release dosage form with two cores

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU2003220466A Abandoned AU2003220466A1 (en)	2002-09-28	2003-03-21	Delayed release dosage forms

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
AU2003218359A Abandoned AU2003218359A1 (en)	2002-09-28	2003-03-21	Polymer composition and dosage forms comprising the same
AU2003220472A Abandoned AU2003220472A1 (en)	2002-09-28	2003-03-21	Modified release dosage form with two cores

Country Status (8)

Country	Link
JP (3)	JP2006517514A (en)
CN (3)	CN1700907A (en)
AT (1)	ATE444739T1 (en)
AU (4)	AU2003220466A1 (en)
BR (5)	BR0314787A (en)
CA (3)	CA2500313C (en)
DE (2)	DE60335270D1 (en)
MX (1)	MXPA05003283A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2470463C (en)	2004-06-09	2012-09-18	Lornamead Brands, Inc.	Tooth whitening products and methods of making the same
SA07280459B1 (en) *	2006-08-25	2011-07-20	بيورديو فارما إل. بي.	Tamper Resistant Oral Pharmaceutical Dosage Forms Comprising an Opioid Analgesic
WO2009153635A1 (en) *	2008-06-19	2009-12-23	University Of Witwatersrand, Johannesburg	A chronotherapeutic pharmaceutical dosage form
JPWO2011118454A1 (en) *	2010-03-23	2013-07-04	リンテック株式会社	Solid preparation
JP6049712B2 (en) *	2011-07-08	2016-12-21	ザユニバーシティオブノースカロライナアットチャペルヒルＴｈｅＵｎｉｖｅｒｓｉｔｙＯｆＮｏｒｔｈＣａｒｏｌｉｎａＡｔＣｈａｐｅｌＨｉｌｌ	Metal bisphosphonate nanoparticles for anti-cancer treatment and imaging and bone disorder treatment
HK1203162A1 (en) *	2012-02-07	2015-10-23	麦克内尔-Ppc股份有限公司	Rapidly disintegrating coated tablets
US9693962B2 (en) *	2012-06-05	2017-07-04	Takeda Pharmaceutical Limited	Dry-coated tablet
WO2016044704A1 (en) *	2014-09-19	2016-03-24	The Procter & Gamble Company	Pulsed release phenylephrine dosage forms
IL273627B2 (en)	2017-12-20	2025-03-01	Purdue Pharma Lp	Abuse deterrent morphine sulfate dosage forms
AU2017445093B2 (en) *	2017-12-29	2024-09-19	Exentis Knowledge Gmbh	Drug delivery system
AU2022320730A1 (en) *	2021-07-30	2024-03-14	Evecxia Therapeutics, Inc.	5-hydroxytryptophan gastroretentive dosage forms
US12409163B2 (en)	2021-07-30	2025-09-09	Evecxia Therapeutics, Inc.	Method of enhancing 5-hydroxytryptophan (5-HTP) exposure
CN115295864B (en) *	2021-11-09	2023-08-11	深圳市德方创域新能源科技有限公司	Positive electrode lithium supplementing additive and preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0662824A1 (en) *	1992-09-30	1995-07-19	Pfizer Inc.	Article containing a core and a coating having a non constant thickness
GB9402203D0 (en) *	1994-02-04	1994-03-30	Smithkline Beecham Plc	Pharmaceutical formulation
DE4431653C2 (en) *	1994-09-06	2000-01-20	Lohmann Therapie Syst Lts	Coated tablet for the controlled release of active substances, a process for their preparation and their use
IT1282576B1 (en) *	1996-02-06	1998-03-31	Jagotec Ag	PHARMACEUTICAL TABLET SUITABLE TO GIVE THE ACTIVE SUBSTANCE IN SUBSEQUENT AND PREDETERMINABLE TIMES
US6602521B1 (en) *	1998-09-29	2003-08-05	Impax Pharmaceuticals, Inc.	Multiplex drug delivery system suitable for oral administration
AU2001250646A1 (en) *	2000-04-17	2001-10-30	Yamanouchi Pharmaceutical Co..Ltd.	Drug delivery system for avoiding pharmacokinetic interaction between drugs and method thereof
ATE324871T1 (en) *	2001-02-13	2006-06-15	Astrazeneca Ab	NEW MODIFIED RELEASE FORMULATION

2003
- 2003-03-21 BR BR0314787-8A patent/BR0314787A/en not_active IP Right Cessation
- 2003-03-21 AU AU2003220466A patent/AU2003220466A1/en not_active Abandoned
- 2003-03-21 AU AU2003225944A patent/AU2003225944A1/en not_active Abandoned
- 2003-03-21 JP JP2004539767A patent/JP2006517514A/en active Pending
- 2003-03-21 CA CA2500313A patent/CA2500313C/en not_active Expired - Fee Related
- 2003-03-21 DE DE60335270T patent/DE60335270D1/en not_active Expired - Lifetime
- 2003-03-21 DE DE60329614T patent/DE60329614D1/en not_active Expired - Lifetime
- 2003-03-21 BR BR0314781-9A patent/BR0314781A/en not_active Application Discontinuation
- 2003-03-21 JP JP2004539769A patent/JP2006517182A/en active Pending
- 2003-03-21 AU AU2003218359A patent/AU2003218359A1/en not_active Abandoned
- 2003-03-21 JP JP2004539770A patent/JP2006517183A/en active Pending
- 2003-03-21 BR BR0314804-1A patent/BR0314804A/en not_active Application Discontinuation
- 2003-03-21 CN CN03825324.0A patent/CN1700907A/en active Pending
- 2003-03-21 MX MXPA05003283A patent/MXPA05003283A/en unknown
- 2003-03-21 BR BR0314777-0A patent/BR0314777A/en not_active Application Discontinuation
- 2003-03-21 CA CA002500312A patent/CA2500312A1/en not_active Abandoned
- 2003-03-21 AT AT03714356T patent/ATE444739T1/en not_active IP Right Cessation
- 2003-03-21 AU AU2003220472A patent/AU2003220472A1/en not_active Abandoned
- 2003-03-21 CA CA002500311A patent/CA2500311A1/en not_active Abandoned
- 2003-03-21 CN CN03823065.8A patent/CN1684671A/en active Pending
- 2003-03-21 CN CN03825331.3A patent/CN1700908A/en active Pending
- 2003-03-21 BR BR0314547-6A patent/BR0314547A/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR0314547A (en)	2005-08-09
CA2500312A1 (en)	2004-04-08
BR0314804A (en)	2005-08-02
BR0314777A (en)	2005-07-26
JP2006517183A (en)	2006-07-20
ATE444739T1 (en)	2009-10-15
DE60329614D1 (en)	2009-11-19
AU2003218359A1 (en)	2004-04-19
CN1700908A (en)	2005-11-23
CN1700907A (en)	2005-11-23
CN1684671A (en)	2005-10-19
JP2006517514A (en)	2006-07-27
JP2006517182A (en)	2006-07-20
AU2003220472A1 (en)	2004-04-19
AU2003220466A1 (en)	2004-04-19
CA2500313C (en)	2011-06-07
CA2500313A1 (en)	2004-04-08
MXPA05003283A (en)	2005-11-23
CA2500311A1 (en)	2004-04-08
BR0314787A (en)	2005-07-26
BR0314781A (en)	2005-07-26
DE60335270D1 (en)	2011-01-20

Publication	Publication Date	Title
AU2003266321A1 (en)	2004-04-08	Tetrahydropyrimidine-2-one derivatives and their uses
AU2003241478A1 (en)	2003-12-22	Nanoparticulate sterol formulations and sterol combinations
AU2003226094A1 (en)	2003-10-13	Compounds and methods
AU2003295572A1 (en)	2004-06-15	Value innovation management system and methods
AU2003250540A1 (en)	2004-02-25	Retarder and circular polarizer
AU2003239484A1 (en)	2003-12-22	Zooplankton enrichment with probionts and prebionts and uses thereof
AU2003267290A1 (en)	2004-04-08	Precast safety end and form therefor
AU2003225944A1 (en)	2004-04-19	Modified release dosage forms with two cores and an opening
AU2003296369A1 (en)	2004-06-30	Imminoamines and preparation thereof
AU2003286847A1 (en)	2004-05-25	Solid state inducting device
AU2003215257A1 (en)	2003-09-09	Modified defensins and their use
AU2003299943A1 (en)	2004-07-22	Heterocycles and uses thereof
AU2003207824A1 (en)	2003-10-20	K-type polarizer and preparation thereof
AU2003251766A1 (en)	2004-01-23	Partially ester-exchanged sipm and process therewith
AU2003268795A1 (en)	2004-04-19	Pallets and methods for manufacture and use thereof
AU2003298129A1 (en)	2004-06-15	Floor-furnace chimney and the use thereof
AU2003283727A1 (en)	2004-07-14	Recording start and stop
AU2003267361A1 (en)	2004-04-30	Orthopoxvirus antigens and use thereof
AU2003212891A1 (en)	2003-10-20	K-type polarizer and preparation thereof
AU2003281691A1 (en)	2004-02-16	Furoisoquinoline derivative and use thereof
AU2003289369A1 (en)	2004-07-09	Message doll and message doll set
AU2003231827A1 (en)	2003-12-12	Pseudo-tissues and uses thereof
AUPS167602A0 (en)	2002-05-16	An improved modified release preparation
AU2003302173A1 (en)	2004-07-14	Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003256998A1 (en)	2004-02-16	Aperture forming means and package

Legal Events

Date	Code	Title	Description
2005-06-16	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase